| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.091 | 0.1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |